Evolent Health, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Evolent Health, Inc. (EVH) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$540.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-25
- Evolent Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$540.00M.
- Evolent Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$68.40M.
- Evolent Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$206.34M.
- Evolent Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$66.06M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$540.00M 10-K · filed 2026-02-25 | |
| 2024-12-31 | -$68.40M 10-K · filed 2026-02-25 | |
| 2023-12-31 | -$206.34M 10-K · filed 2026-02-25 | |
| 2022-12-31 | -$66.06M 10-K · filed 2025-02-21 | |
| 2021-12-31 | -$32.72M 10-K · filed 2024-02-23 | |
| 2020-12-31 | -$332.37M 10-K · filed 2023-02-24 | -$339.63M 10-K · filed 2021-02-26 |
| 2019-12-31 | -$331.03M 10-K · filed 2022-02-24 | -$328.16M 10-K · filed 2020-03-02 |
| 2018-12-31 | -$54.68M 10-K · filed 2021-02-26 | |
| 2017-12-31 | -$76.40M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |